Devon Elizabeth Driver
Nurse Practitioner · Columbia
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Carolina Dermatology Grp · 27 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Devon Elizabeth Driver’s office at (803) 771-7506 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$193,388
Medicare paid this office $193,388 for 860 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 663 | $50,325 | $49 |
| Return visit (30+ min) | 329 | $34,954 | $69 |
| Destruction of skin growth, 1-14 growths | 272 | $25,289 | $63 |
| Destruction of precancer skin growth, 1 growth | 452 | $22,663 | $29 |
| Biopsy of related skin growth, first growth | 188 | $11,706 | $48 |
See all 21 services
| Short return visit (20+ min) | 663 | $50,325 | $49 |
| Return visit (30+ min) | 329 | $34,954 | $69 |
| Destruction of skin growth, 1-14 growths | 272 | $25,289 | $63 |
| Destruction of precancer skin growth, 1 growth | 452 | $22,663 | $29 |
| Biopsy of related skin growth, first growth | 188 | $11,706 | $48 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 17 | $11,542 | None |
| Destruction of precancer skin growth, 2-14 growths | 345 | $7,410 | $4 |
| Application of light by qualified health care professional to destroy precancer skin growth | 17 | $3,755 | $117 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | $2,263 | $189 |
| Short return visit | 59 | $2,169 | $32 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $2,085 | $95 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 19 | $2,024 | $92 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $1,900 | $100 |
| New patient visit (30+ min) | 36 | $1,765 | $49 |
| Biopsy of related skin growth, each additional growth | 32 | $1,534 | $30 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 19 | $1,478 | $74 |
| New patient visit (45+ min) | 13 | $1,206 | $93 |
| Injection into skin growth, 1-7 growths | 19 | $699 | $23 |
| Biopsy of ear | 12 | $564 | $47 |
| Injection of drug or substance under skin or into muscle | 11 | $207 | $8 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $37 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 16 | More than 71% of doctors who do this |
| Removal of skin lesions | 1939 | More than 98% of doctors who do this |
| Removal or shaving of skin growth | 20 | More than 71% of doctors who do this |
| Skin biopsy | 316 | More than 91% of doctors who do this |
Who their Medicare patients are
860 Original Medicare patients in 2024. Average age 74 · Under 65 3% · 85 and older 8% · Women 59% · Also on Medicaid 2% · Health risk score 0.81. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 72% · Coronary heart disease 27% · Diabetes 25% · Chronic kidney disease 17% · Cancer 17% · Atrial fibrillation 16% · Depression 14% · Heart failure 10% · COPD 8% · Stroke 4% · Dementia 3%.
The office billed $831,405, Medicare allowed $277,037 and paid $193,388; for 5,510 services of 52 kinds; $11,579 of it was for drugs given in the office and $181,809 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 860 | 5,510 | 74 | 0.81 | $831,405 | $193,388 |
| 2023 | 592 | 2,461 | 74 | 0.81 | $201,353 | $83,164 |
| 2022 | 570 | 2,101 | 73 | 0.79 | $170,642 | $67,114 |
| 2021 | 512 | 2,111 | 73 | 0.81 | $154,748 | $61,470 |
| 2020 | 409 | 1,584 | 73 | 0.84 | $117,504 | $42,192 |
| 2019 | 337 | 1,243 | 72 | 0.89 | $93,454 | $33,390 |
| 2018 | 192 | 488 | 71 | 0.87 | $36,853 | $13,202 |
| 2017 | 48 | 120 | 71 | 0.78 | $8,740 | $3,292 |
| 2016 | 635 | 2,436 | 74 | 0.85 | $112,526 | $50,262 |
| 2015 | 1,197 | 5,961 | 74 | 0.84 | $282,033 | $153,936 |
| 2014 | 1,192 | 6,095 | 74 | 0.79 | $320,819 | $179,772 |
| 2013 | 253 | 1,024 | 74 | 0.75 | $58,064 | $34,214 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 274 | $23,719 | $69 |
| Short return visit (20+ min) | 270 | $15,422 | $49 |
| Destruction of skin growth, 1-14 growths | 170 | $12,836 | $63 |
| Destruction of precancer skin growth, 1 growth | 267 | $10,160 | $29 |
| Biopsy of related skin growth, first growth | 139 | $7,947 | $51 |
| Destruction of precancer skin growth, 2-14 growths | 195 | $3,241 | $4 |
| Short return visit | 73 | $2,244 | $30 |
| Destruction of skin growth, 15 or more growths | 17 | $1,832 | $70 |
| Biopsy of related skin growth, each additional growth | 29 | $1,170 | $30 |
| Biopsy of ear | 12 | $486 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $26 | None |
2022: 11 services
| Return visit (30+ min) | 214 | $16,341 | $65 |
| Short return visit (20+ min) | 250 | $13,372 | $48 |
| Destruction of skin growth, 1-14 growths | 152 | $10,727 | $61 |
| Destruction of precancer skin growth, 1 growth | 222 | $8,189 | $30 |
| Biopsy of related skin growth, first growth | 136 | $7,251 | $50 |
| Destruction of precancer skin growth, 2-14 growths | 166 | $2,721 | $4 |
| Short return visit | 90 | $2,649 | $28 |
| New patient visit (45+ min) | 12 | $1,067 | $89 |
| Destruction of precancer skin growth, 15 or more growths | 11 | $935 | $85 |
| Biopsy of related skin growth, each additional growth | 25 | $781 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $27 | None |
2021: 11 services
| Short return visit (20+ min) | 199 | $11,715 | $52 |
| Destruction of skin growth, 1-14 growths | 123 | $8,893 | $60 |
| Return visit (30+ min) | 117 | $8,696 | $67 |
| Destruction of precancer skin growth, 1 growth | 219 | $7,751 | $28 |
| Biopsy of related skin growth, first growth | 121 | $6,705 | $52 |
| Short return visit | 179 | $6,495 | $33 |
| Destruction of precancer skin growth, 2-14 growths | 166 | $2,814 | $4 |
| Long return visit (40+ min) | 14 | $879 | $63 |
| Biopsy of related skin growth, each additional growth | 15 | $542 | $34 |
| Injection into skin growth, 1-7 growths | 14 | $526 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $53 | None |
2020: 10 services
| Destruction of skin growth, 1-14 growths | 108 | $8,124 | $62 |
| Short return visit (20+ min) | 155 | $6,762 | $40 |
| Short return visit | 189 | $5,975 | $26 |
| Destruction of precancer skin growth, 1 growth | 180 | $5,840 | $27 |
| Biopsy of related skin growth, first growth | 106 | $5,618 | $50 |
| Return visit (30+ min) | 69 | $4,078 | $57 |
| Destruction of precancer skin growth, 2-14 growths | 129 | $1,719 | $3 |
| Biopsy of related skin growth, each additional growth | 15 | $552 | $31 |
| Injection into skin growth, 1-7 growths | 12 | $356 | $24 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $31 | None |
2019: 9 services
| Short return visit (20+ min) | 118 | $5,292 | $40 |
| Destruction of skin growth, 1-14 growths | 82 | $5,275 | $58 |
| Biopsy of related skin growth, first growth | 100 | $5,033 | $49 |
| Short return visit | 146 | $4,103 | $25 |
| Destruction of precancer skin growth, 1 growth | 136 | $3,785 | $25 |
| Return visit (30+ min) | 53 | $3,326 | $62 |
| Destruction of precancer skin growth, 2-14 growths | 105 | $1,234 | $3 |
| Biopsy of related skin growth, each additional growth | 18 | $636 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $24 | None |
2018: 8 services
| Short return visit | 91 | $2,197 | $23 |
| Biopsy of single growth of skin and/or tissue | 35 | $1,993 | $55 |
| Destruction of precancer skin growth, 1 growth | 61 | $1,938 | $31 |
| Destruction of skin growth, 1-14 growths | 28 | $1,932 | $60 |
| Short return visit (20+ min) | 41 | $1,816 | $41 |
| Return visit (30+ min) | 15 | $961 | $64 |
| New patient visit (15+ min) | 14 | $619 | $44 |
| Destruction of precancer skin growth, 2-14 growths | 45 | $455 | $3 |
2017: 3 services
| Biopsy of single growth of skin and/or tissue | 13 | $714 | $55 |
| Short return visit | 21 | $617 | $27 |
| Short return visit (20+ min) | 12 | $512 | $43 |
2016: 16 services
| Destruction of precancer skin growth, 1 growth | 322 | $9,029 | $26 |
| Short return visit (20+ min) | 262 | $8,597 | $31 |
| Biopsy of single growth of skin and/or tissue | 144 | $7,320 | $50 |
| Return visit (30+ min) | 131 | $6,745 | $49 |
| Short return visit | 157 | $3,087 | $19 |
| Destruction of precancer skin growth, 15 or more growths | 35 | $2,741 | $69 |
| Destruction of precancer skin growth, 2-14 growths | 230 | $2,633 | $3 |
| New patient visit (15+ min) | 56 | $1,315 | $23 |
| New patient visit (30+ min) | 39 | $1,181 | $30 |
| Biopsy of each additional growth of skin and/or tissue | 41 | $1,008 | $19 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 16 | $1,004 | $59 |
| Shaving of skin growth of body, arms, or legs, 0.5 cm or less | 21 | $919 | $40 |
| Destruction of skin growth, 1-14 growths | 19 | $807 | $42 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 12 | $406 | $31 |
| Injection into skin growth, 1-7 growths | 19 | $343 | $15 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $19 | None |
2015: 22 services
| Destruction of precancer skin growth, 1 growth | 583 | $24,634 | $31 |
| Short return visit (20+ min) | 476 | $24,057 | $40 |
| Biopsy of single growth of skin and/or tissue | 371 | $23,774 | $56 |
| Return visit (30+ min) | 212 | $15,013 | $56 |
| Destruction of precancer skin growth, 15 or more growths | 93 | $10,293 | $90 |
| Destruction of precancer skin growth, 2-14 growths | 408 | $7,587 | $3 |
| New patient visit (30+ min) | 142 | $7,427 | $52 |
| Short return visit | 268 | $7,230 | $24 |
| New patient visit (15+ min) | 155 | $5,677 | $37 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 54 | $3,766 | $66 |
| Biopsy of each additional growth of skin and/or tissue | 113 | $3,548 | $20 |
| Shaving of skin growth of body, arms, or legs, 0.5 cm or less | 68 | $3,438 | $44 |
| Destruction of skin growth, 1-14 growths | 53 | $3,198 | $58 |
| Injection into skin growth, 1-7 growths | 50 | $1,735 | $23 |
| Biopsy of ear | 30 | $1,714 | $46 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | 28 | $1,694 | $60 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 32 | $1,672 | $49 |
| Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $1,079 | $83 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 18 | $1,018 | $57 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 14 | $1,015 | $72 |
| New patient visit (10+ min) | 55 | $991 | $18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 54 | $86 | None |
2014: 22 services
| Destruction of precancer skin growth, 1 growth | 612 | $27,741 | $35 |
| Biopsy of single growth of skin and/or tissue | 390 | $25,204 | $54 |
| Short return visit (20+ min) | 474 | $24,277 | $40 |
| Return visit (30+ min) | 222 | $17,224 | $59 |
| Destruction of precancer skin growth, 15 or more growths | 141 | $15,741 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 427 | $13,396 | $6 |
| New patient visit (30+ min) | 175 | $9,263 | $53 |
| Short return visit | 259 | $6,949 | $23 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 99 | $6,883 | $62 |
| Destruction of skin growth, 1-14 growths | 98 | $6,075 | $58 |
| Shaving of skin growth of body, arms, or legs, 0.5 cm or less | 94 | $4,982 | $45 |
| New patient visit (15+ min) | 130 | $4,772 | $37 |
| Biopsy of each additional growth of skin and/or tissue | 134 | $4,586 | $20 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | 28 | $1,869 | $64 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 22 | $1,631 | $65 |
| Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | 19 | $1,485 | $74 |
| Biopsy of ear | 26 | $1,455 | $44 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 21 | $1,344 | $61 |
| Injection into skin growth, 1-7 growths | 27 | $964 | $27 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 15 | $639 | $43 |
| New patient visit (10+ min) | 18 | $391 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 28 | $43 | None |
2013: 11 services
| Destruction of precancer skin growth, 1 growth | 118 | $5,158 | $41 |
| Biopsy of single growth of skin and/or tissue | 82 | $4,662 | $56 |
| Destruction of precancer skin growth, 15 or more growths | 37 | $3,927 | $106 |
| Return visit (30+ min) | 56 | $3,636 | $65 |
| Short return visit (20+ min) | 71 | $3,347 | $45 |
| New patient visit (30+ min) | 45 | $2,806 | $62 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 22 | $1,697 | $68 |
| Destruction of precancer skin growth, 2-14 growths | 80 | $1,604 | $4 |
| Biopsy of each additional growth of skin and/or tissue | 36 | $1,474 | $20 |
| Destruction of skin growth, 1-14 growths | 23 | $1,470 | $64 |
| Short return visit | 38 | $1,034 | $27 |
Drugs they prescribed that Part D paid
$1,078,113
Pharmacies billed $1,078,113 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,100) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
959 generic and 141 brand-name prescriptions · $1,078,113 in drug cost · 74 antibiotic prescriptions to 42 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cosentyx Unoready | 28 | $370,224 | $13,222 |
| Dupixent | 22 | $140,363 | $6,380 |
| Otezla | 12 | $63,369 | $5,281 |
| Ketoconazole | 171 | $3,413 | $20 |
| Clobetasol Propionate | 80 | $3,042 | $38 |
See all 24 drugs
| Cosentyx Unoready | 28 | $370,224 | $13,222 |
| Dupixent | 22 | $140,363 | $6,380 |
| Otezla | 12 | $63,369 | $5,281 |
| Ketoconazole | 171 | $3,413 | $20 |
| Clobetasol Propionate | 80 | $3,042 | $38 |
| Fluorouracil | 32 | $2,493 | $78 |
| Tacrolimus | 18 | $2,337 | $130 |
| Doxycycline Hyclate | 56 | $2,084 | $37 |
| Calcipotriene | 18 | $1,846 | $103 |
| Ammonium Lactate | 62 | $1,259 | $20 |
| Mometasone Furoate | 55 | $947 | $17 |
| Metronidazole | 31 | $929 | $30 |
| Azelaic Acid | 12 | $823 | $69 |
| Triamcinolone Acetonide | 62 | $732 | $12 |
| Clindamycin Phosphate | 26 | $655 | $25 |
| Minoxidil | 72 | $637 | $9 |
| Mupirocin | 57 | $485 | $9 |
| Gentamicin Sulfate | 16 | $423 | $26 |
| Fluocinolone Acetonide | 12 | $308 | $26 |
| Hydrocortisone | 47 | $242 | $5 |
| Fluconazole | 17 | $214 | $13 |
| Nystatin | 17 | $188 | $11 |
| Spironolactone | 13 | $160 | $12 |
| Terbinafine | 16 | $66 | $4 |
Year by year
| 2024 | 1,100 | 349 | 0% (0) | 13% | $1,078,113 |
| 2023 | 49 | 31 | 0% (0) | 27% | $193,443 |
| 2022 | 77 | 44 | 0% (0) | 21% | $120,238 |
| 2021 | 63 | 37 | 0% (0) | None | $6,426 |
| 2020 | 86 | 56 | 0% (0) | 21% | $113,216 |
| 2019 | 38 | 24 | 0% (0) | 39% | $49,625 |
| 2018 | 78 | 49 | 0% (0) | 23% | $46,612 |
| 2017 | 53 | 41 | 0% (0) | None | $12,236 |
| 2016 | 455 | 225 | 0% (0) | 20% | $141,222 |
| 2015 | 702 | 336 | 0% (0) | 22% | $158,236 |
| 2014 | 436 | 270 | 0% (0) | 21% | $31,298 |
| 2013 | 73 | 52 | 0% (0) | 30% | $4,648 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Otezla | 11 | $36,937 | $3,358 |
2016: 14 drugs
| Otezla | 29 | $66,427 | $2,291 |
| Clobetasol Propionate | 16 | $2,206 | $138 |
| Desoximetasone | 13 | $1,389 | $107 |
| Desonide | 13 | $1,234 | $95 |
| Clindamycin Phosphate | 12 | $1,134 | $94 |
| Doxycycline Hyclate | 11 | $1,029 | $94 |
| Mupirocin | 82 | $677 | $8 |
| Ketoconazole | 25 | $657 | $26 |
| Mometasone Furoate | 30 | $566 | $19 |
| Triamcinolone Acetonide | 12 | $499 | $42 |
| Clotrimazole-Betamethasone | 11 | $445 | $40 |
| Ammonium Lactate | 14 | $402 | $29 |
| Acyclovir | 12 | $200 | $17 |
| Cefadroxil | 19 | $86 | $5 |
2015: 19 drugs
| Otezla | 34 | $72,518 | $2,133 |
| Clobetasol Propionate | 43 | $31,704 | $737 |
| Desonide | 36 | $3,730 | $104 |
| Doxycycline Hyclate | 31 | $2,973 | $96 |
| Fluocinolone Acetonide | 16 | $2,685 | $168 |
| Econazole Nitrate | 11 | $2,088 | $190 |
| Hydrocortisone Butyrate | 26 | $1,914 | $74 |
| Desoximetasone | 12 | $1,900 | $158 |
| Clindamycin Phosphate | 25 | $1,540 | $62 |
| Fluocinonide | 22 | $1,433 | $65 |
| Mometasone Furoate | 65 | $1,001 | $15 |
| Mupirocin | 83 | $765 | $9 |
| Ammonium Lactate | 27 | $664 | $25 |
| Clotrimazole-Betamethasone | 19 | $633 | $33 |
| Triamcinolone Acetonide | 16 | $490 | $31 |
| Ketoconazole | 21 | $422 | $20 |
| Levocetirizine Dihydrochloride | 32 | $311 | $10 |
| Nystatin | 12 | $265 | $22 |
| Cefadroxil | 30 | $166 | $6 |
2014: 14 drugs
| Desonide | 36 | $4,056 | $113 |
| Fluocinolone Acetonide | 13 | $2,295 | $177 |
| Doxycycline Hyclate | 11 | $2,185 | $199 |
| Clindamycin Phosphate | 22 | $1,989 | $90 |
| Fluocinolone Acetonide Oil | 12 | $1,896 | $158 |
| Mometasone Furoate | 58 | $1,212 | $21 |
| Hydrocortisone Butyrate | 20 | $1,085 | $54 |
| Mupirocin | 51 | $610 | $12 |
| Fluocinonide | 18 | $575 | $32 |
| Levocetirizine Dihydrochloride | 26 | $457 | $18 |
| Ammonium Lactate | 18 | $306 | $17 |
| Triamcinolone Acetonide | 13 | $259 | $20 |
| Ketoconazole | 22 | $246 | $11 |
| Cefadroxil | 13 | $75 | $6 |
2013: 1 drug
| Desonide | 15 | $1,654 | $110 |
Money from drug and device companies
$5,102 in 2025
| 2025 | 21 | 196 | $1,140 | $5,102 |
| 2024 | 19 | 168 | None | $3,277 |
| 2023 | 25 | 310 | None | $5,298 |
| 2022 | 24 | 257 | None | $4,055 |
| 2021 | 21 | 213 | None | $3,651 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | Bimzelx | $1,529 | 18 payments
|
| Regeneron Healthcare Solutions | Dupixent | $462 | 15 payments
|
| Abbvie | Skyrizi | $428 | 27 payments
|
| Arcutis Biotherapeutics | Zoryve | $379 | 9 payments
|
| Sun Pharmaceutical Industries | Ilumya | $295 | 12 payments
|
| Mayne Pharma Commercial | None | $232 | 17 payments
|
See all 195 published payments
| Ucb | Meals · 2025-12-22 | Bimzelx | $25 |
| Novartis Pharmaceuticals | Meals · 2025-12-18 | Cosentyx | $28 |
| Abbvie | Meals · 2025-12-18 | Skyrizi | $30 |
| Organon | Meals · 2025-12-16 | None | $18 |
| Janssen Biotech | Meals · 2025-12-15 | Tremfya | $21 |
| Amgen | Meals · 2025-12-11 | Otezla | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-12-10 | Leqselvi | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-12-09 | Dupixent | $34 |
| Incyte | Meals · 2025-12-08 | Opzelura | $23 |
| Arcutis Biotherapeutics | Meals · 2025-12-08 | Zoryve | $7 |
| Arcutis Biotherapeutics | Meals · 2025-12-03 | Zoryve | $8 |
| Janssen Biotech | Meals · 2025-12-02 | Tremfya | $17 |
| Abbvie | Meals · 2025-12-01 | Skyrizi | $30 |
| Cipher Pharmaceuticals US | Meals · 2025-12-01 | Natroba | $19 |
| Botanix SB | Meals · 2025-11-25 | Sofdra | $21 |
| Ucb | Meals · 2025-11-24 | Bimzelx | $20 |
| Abbvie | Meals · 2025-11-20 | Rinvoq | $12 |
| Genzyme | Meals · 2025-11-20 | Dupixent | $38 |
| Arcutis Biotherapeutics | Meals · 2025-11-18 | Zoryve | $6 |
| Amgen | Meals · 2025-11-17 | Otezla | $23 |
| Incyte | Meals · 2025-11-13 | Opzelura | $25 |
| Sun Pharmaceutical Industries | Meals · 2025-11-12 | Winlevi | $16 |
| Pfizer | Meals · 2025-11-11 | Cibinqo | $23 |
| Janssen Biotech | Meals · 2025-11-10 | Tremfya | $19 |
| Janssen Biotech | Meals · 2025-11-10 | Tremfya | $1 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Cosentyx | $34 |
| Amgen | Meals · 2025-11-06 | Otezla | $3 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-05 | Sotyktu | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-11-04 | Dupixent | $32 |
| Arcutis Biotherapeutics | Meals · 2025-11-03 | Zoryve | $6 |
| Abbvie | Meals · 2025-10-31 | Skyrizi | $9 |
| Incyte | Meals · 2025-10-31 | Opzelura | $9 |
| Lilly USA | Meals · 2025-10-29 | Taltz | $23 |
| Ucb | Meals · 2025-10-27 | Bimzelx | $22 |
| Lilly USA | Meals · 2025-10-24 | Taltz | $21 |
| Abbvie | Meals · 2025-10-22 | Skyrizi | $27 |
| LEO Pharma | Meals · 2025-10-20 | Spevigo | $21 |
| Pfizer | Meals · 2025-10-16 | Cibinqo | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-10-16 | Leqselvi | $18 |
| Arcutis Biotherapeutics | Meals · 2025-10-16 | Zoryve | $21 |
| Abbvie | Meals · 2025-10-15 | Rinvoq | $17 |
| Amgen | Meals · 2025-10-15 | Otezla | $15 |
| Organon | Meals · 2025-10-14 | None | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-10-09 | Dupixent | $35 |
| Ucb | Meals · 2025-10-08 | Bimzelx | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-07 | Sotyktu | $22 |
| Novartis Pharmaceuticals | Meals · 2025-10-06 | Cosentyx | $17 |
| Janssen Biotech | Meals · 2025-10-01 | Tremfya | $18 |
| Arcutis Biotherapeutics | Meals · 2025-09-30 | Zoryve | $22 |
| Incyte | Meals · 2025-09-26 | Opzelura | $9 |
| Genzyme | Meals · 2025-09-25 | Dupixent | $40 |
| Arcutis Biotherapeutics | Meals · 2025-09-25 | Zoryve | $108 |
| Amgen | Meals · 2025-09-23 | Otezla | $27 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-22 | Cabtreo | $19 |
| Ucb | Meals · 2025-09-22 | Bimzelx | $23 |
| Novartis Pharmaceuticals | Meals · 2025-09-17 | Cosentyx | $15 |
| Abbvie | Meals · 2025-09-17 | Rinvoq | $11 |
| Ucb | Consulting · 2025-09-16 | Bimzelx | $1,140 |
| LEO Pharma | Meals · 2025-09-16 | Anzupgo | $14 |
| Janssen Biotech | Meals · 2025-09-15 | Tremfya | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-09-11 | Dupixent | $35 |
| Ucb | Meals · 2025-09-05 | Bimzelx | $46 |
| LEO Pharma | Meals · 2025-09-04 | Anzupgo | $31 |
| Galderma Laboratories L.P. | Meals · 2025-09-03 | Nemluvio | $23 |
| Ucb | Meals · 2025-09-02 | Bimzelx | $26 |
| Incyte | Meals · 2025-08-29 | Opzelura | $14 |
| Abbvie | Meals · 2025-08-27 | Skyrizi | $8 |
| Janssen Biotech | Meals · 2025-08-26 | Tremfya | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-25 | Spevigo | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-08-23 | Dupixent | $33 |
| Amgen | Meals · 2025-08-19 | Otezla | $8 |
| Abbvie | Meals · 2025-08-18 | Rinvoq | $24 |
| Novartis Pharmaceuticals | Meals · 2025-08-14 | Cosentyx | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-08-13 | Dupixent | $31 |
| Organon | Meals · 2025-08-12 | None | $27 |
| Janssen Biotech | Meals · 2025-08-11 | Tremfya | $18 |
| Arcutis Biotherapeutics | Meals · 2025-08-07 | Zoryve | $106 |
| Genzyme | Meals · 2025-08-06 | Dupixent | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-05 | Sotyktu | $9 |
| Ucb | Meals · 2025-08-04 | Bimzelx | $26 |
| Abbvie | Meals · 2025-07-30 | Skyrizi | $23 |
| Mayne Pharma Commercial | Meals · 2025-07-28 | None | $13 |
| Incyte | Meals · 2025-07-25 | Opzelura | $16 |
| Abbvie | Meals · 2025-07-23 | Rinvoq | $12 |
| Amgen | Meals · 2025-07-23 | Otezla | $18 |
| Pfizer | Meals · 2025-07-22 | Cibinqo | $21 |
| Mayne Pharma Commercial | Meals · 2025-07-21 | None | $21 |
| Sun Pharmaceutical Industries | Meals · 2025-07-17 | Ilumya | $24 |
| Sun Pharmaceutical Industries | Education · 2025-07-16 | None | $100 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-15 | Sotyktu | $25 |
| Janssen Biotech | Meals · 2025-07-14 | Tremfya | $18 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-07-14 | Cabtreo | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-11 | Sotyktu | $5 |
| Novartis Pharmaceuticals | Meals · 2025-07-10 | Cosentyx | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-07-09 | Dupixent | $37 |
| Ucb | Meals · 2025-07-08 | Bimzelx | $24 |
| Mayne Pharma Commercial | Meals · 2025-07-07 | None | $19 |
| Genzyme | Meals · 2025-06-30 | Dupixent | $18 |
| Pfizer | Meals · 2025-06-25 | Cibinqo | $18 |
| Amgen | Meals · 2025-06-25 | Otezla | $4 |
| Lilly USA | Meals · 2025-06-24 | Taltz | $22 |
| Amgen | Meals · 2025-06-23 | Otezla | $23 |
| Mayne Pharma Commercial | Meals · 2025-06-23 | None | $15 |
| Arcutis Biotherapeutics | Meals · 2025-06-19 | Zoryve | $95 |
| Abbvie | Meals · 2025-06-18 | Skyrizi | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-17 | Sotyktu | $11 |
| Sun Pharmaceutical Industries | Meals · 2025-06-17 | Ilumya | $16 |
| Mayne Pharma Commercial | Meals · 2025-06-16 | None | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-06-11 | Dupixent | $32 |
| Ucb | Meals · 2025-06-09 | Bimzelx | $22 |
| Mayne Pharma Commercial | Meals · 2025-06-09 | None | $19 |
| Abbvie | Meals · 2025-06-06 | Skyrizi | $8 |
| Abbvie | Meals · 2025-06-06 | Skyrizi | $0 |
| Abbvie | Meals · 2025-06-04 | Rinvoq | $17 |
| Regeneron Healthcare Solutions | Meals · 2025-06-04 | Dupixent | $14 |
| Incyte | Meals · 2025-05-23 | Opzelura | $11 |
| Abbvie | Meals · 2025-05-22 | Skyrizi | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-20 | Spevigo | $20 |
| Genzyme | Meals · 2025-05-19 | Dupixent | $9 |
| Mayne Pharma Commercial | Meals · 2025-05-19 | None | $16 |
| Sun Pharmaceutical Industries | Meals · 2025-05-16 | Ilumya | $25 |
| Galderma Laboratories L.P. | Meals · 2025-05-14 | Nemluvio | $14 |
| Ucb | Meals · 2025-05-13 | Bimzelx | $20 |
| Organon | Meals · 2025-05-08 | Hadlima | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-05-07 | Dupixent | $27 |
| Mayne Pharma Commercial | Meals · 2025-05-05 | None | $13 |
| LEO Pharma | Meals · 2025-04-30 | Adbry | $28 |
| Genzyme | Education · 2025-04-29 | Dupixent | $8 |
| Genzyme | Meals · 2025-04-29 | Dupixent | $19 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-04-28 | Cabtreo | $17 |
| Ucb | Meals · 2025-04-28 | Bimzelx | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-04-23 | Dupixent | $20 |
| Pfizer | Meals · 2025-04-23 | Cibinqo | $21 |
| Janssen Biotech | Meals · 2025-04-22 | Tremfya | $16 |
| Sun Pharmaceutical Industries | Meals · 2025-04-22 | Ilumya | $11 |
| Mayne Pharma Commercial | Meals · 2025-04-21 | None | $14 |
| Amgen | Meals · 2025-04-17 | Otezla | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-15 | Sotyktu | $20 |
| Incyte | Meals · 2025-04-11 | Opzelura | $28 |
| Abbvie | Meals · 2025-04-10 | Skyrizi | $0 |
| Abbvie | Meals · 2025-04-10 | Skyrizi | $8 |
| Abbvie | Meals · 2025-04-09 | Rinvoq | $8 |
| Mayne Pharma Commercial | Meals · 2025-04-07 | None | $12 |
| Janssen Biotech | Meals · 2025-04-02 | Tremfya | $17 |
| Mayne Pharma Commercial | Meals · 2025-03-31 | None | $10 |
| Ucb | Meals · 2025-03-25 | Bimzelx | $22 |
| Organon | Meals · 2025-03-24 | Vtama | $7 |
| Abbvie | Meals · 2025-03-20 | Skyrizi | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-03-19 | Dupixent | $24 |
| Ucb | Meals · 2025-03-19 | Bimzelx | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-03-18 | Ilumya | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-17 | Sotyktu | $21 |
| Mayne Pharma Commercial | Meals · 2025-03-17 | None | $12 |
| Abbvie | Meals · 2025-03-14 | Skyrizi | $8 |
| Amgen | Meals · 2025-03-13 | Otezla | $21 |
| Genzyme | Meals · 2025-03-10 | Dupixent | $17 |
| Lilly USA | Meals · 2025-03-06 | Taltz | $17 |
| Abbvie | Meals · 2025-03-05 | Skyrizi | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-03-05 | Dupixent | $38 |
| Mayne Pharma Commercial | Meals · 2025-03-03 | None | $11 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-02-28 | Cabtreo | $16 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $26 |
| Abbvie | Meals · 2025-02-26 | Rinvoq | $25 |
| Pfizer | Meals · 2025-02-24 | Cibinqo | $21 |
| Mayne Pharma Commercial | Meals · 2025-02-24 | None | $9 |
| Amgen | Meals · 2025-02-20 | Otezla | $23 |
| Ucb | Meals · 2025-02-19 | Bimzelx | $21 |
| Organon | Meals · 2025-02-17 | Vtama | $21 |
| Incyte | Meals · 2025-02-13 | Opzelura | $26 |
| Genzyme | Meals · 2025-02-13 | Dupixent | $19 |
| Ucb | Meals · 2025-02-12 | Bimzelx | $11 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-11 | Spevigo | $16 |
| Janssen Biotech | Meals · 2025-02-10 | Tremfya | $19 |
| Abbvie | Meals · 2025-02-06 | Skyrizi | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-02-06 | Dupixent | $35 |
| Amgen | Meals · 2025-02-06 | Otezla | $3 |
| Sun Pharmaceutical Industries | Meals · 2025-02-06 | Ilumya | $13 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-04 | Sotyktu | $16 |
| Lilly USA | Meals · 2025-02-03 | Ebglyss | $21 |
| Mayne Pharma Commercial | Meals · 2025-02-03 | None | $11 |
| Galderma Laboratories L.P. | Meals · 2025-01-30 | Nemluvio | $18 |
| Pfizer | Meals · 2025-01-27 | Cibinqo | $22 |
| Mayne Pharma Commercial | Meals · 2025-01-27 | None | $11 |
| Sun Pharmaceutical Industries | Meals · 2025-01-23 | Winlevi | $23 |
| LEO Pharma | Meals · 2025-01-21 | Adbry | $21 |
| Mayne Pharma Commercial | Meals · 2025-01-20 | None | $9 |
| Sun Pharmaceutical Industries | Meals · 2025-01-16 | Ilumya | $19 |
| Abbvie | Meals · 2025-01-15 | Skyrizi | $7 |
| Ucb | Meals · 2025-01-14 | Bimzelx | $19 |
| Amgen | Meals · 2025-01-14 | Otezla | $14 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-01-10 | Cabtreo | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-01-09 | Dupixent | $36 |
| Genzyme | Meals · 2025-01-06 | Dupixent | $4 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-03 | Sotyktu | $3 |
| Abbvie | Meals · 2025-01-02 | Skyrizi | $7 |
See earlier years (2024, 2023, 2022, 2021)
2024: $3,277
| Abbvie | Skyrizi | $525 | 27 payments
|
| Regeneron Healthcare Solutions | Dupixent | $403 | 15 payments
|
| Dermavant Sciences | Vtama | $286 | 15 payments
|
| Sun Pharmaceutical Industries | Ilumya | $281 | 12 payments
|
| Janssen Biotech | Tremfya | $266 | 15 payments
|
| Incyte | Opzelura | $248 | 13 payments
|
| Ucb | Bimzelx | $237 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $180 | 12 payments
|
| Amgen | Otezla | $175 | 11 payments
|
| Pfizer | Eucrisa | $152 | 10 payments
|
| Lilly USA | Taltz | $125 | 7 payments
|
| Arcutis Biotherapeutics | Zoryve | $117 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $95 | 5 payments
|
| Genzyme | Dupixent | $49 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $43 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $40 | 2 payments
|
| LEO Pharma | Adbry | $23 | 1 payment
|
| Almirall | Klisyri | $16 | 1 payment
|
| Galderma Laboratories L.P. | None | $16 | 1 payment
|
2023: $5,298
| Mayne Pharma Commercial | None | $622 | 89 payments
|
| Dermavant Sciences | Vtama | $432 | 15 payments
|
| Regeneron Healthcare Solutions | Dupixent | $424 | 17 payments
|
| Novartis Pharmaceuticals | Cosentyx | $421 | 23 payments
|
| Abbvie | Skyrizi | $416 | 27 payments
|
| Janssen Biotech | Tremfya | $413 | 13 payments
|
| Sun Pharmaceutical Industries | Ilumya | $371 | 13 payments
|
| Amgen | Otezla | $365 | 16 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $330 | 27 payments
|
| Incyte | Opzelura | $243 | 9 payments
|
| Genzyme | Dupixent | $235 | 15 payments
|
| Janssen Scientific Affairs | Tremfya | $150 | 1 payment
|
| LEO Pharma | Adbry | $146 | 7 payments
|
| Ucb | Cimzia | $144 | 6 payments
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $139 | 8 payments
|
| Pfizer | Cibinqo | $89 | 4 payments
|
| Arcutis Biotherapeutics | None | $81 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $72 | 4 payments
|
| Almirall | Seysara | $58 | 3 payments
|
| Lilly USA | Taltz | $50 | 3 payments
|
| Regeneron Pharmaceuticals | Dupixent | $33 | 1 payment
|
| Sebela Pharmaceuticals | Naftin | $19 | 1 payment
|
| Biofrontera | Ameluz | $16 | 1 payment
|
| Medimetriks Pharmaceuticals | Neo-Synalar | $16 | 1 payment
|
| Helsinn Therapeutics (U.S.) | Valchlor | $13 | 1 payment
|
2022: $4,055
| Abbvie | Skyrizi | $514 | 42 payments
|
| Sun Pharmaceutical Industries | Ilumya | $514 | 24 payments
|
| Mayne Pharma | None | $475 | 56 payments
|
| Novartis Pharmaceuticals | Cosentyx | $283 | 21 payments
|
| Regeneron Healthcare Solutions | Dupixent | $250 | 10 payments
|
| Amgen | Otezla | $245 | 12 payments
|
| Janssen Biotech | Tremfya | $216 | 12 payments
|
| Ucb | Cimzia | $197 | 10 payments
|
| Incyte | Opzelura | $195 | 13 payments
|
| Almirall | Klisyri | $163 | 6 payments
|
| Pfizer | Eucrisa | $158 | 9 payments
|
| LEO Pharma | Adbry | $147 | 9 payments
|
| Janssen Scientific Affairs | Tremfya | $108 | 1 payment
|
| EPI Health | Cloderm | $107 | 6 payments
|
| Lilly USA | Taltz | $94 | 7 payments
|
| Medimetriks Pharmaceuticals | Neo-Synalar | $82 | 3 payments
|
| Genzyme | Dupixent | $61 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $53 | 3 payments
|
| Galderma Laboratories L.P. | Twyneo | $53 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $42 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $33 | 2 payments
|
| Journey Medical | Qbrexza | $32 | 2 payments
|
| Dermavant Sciences | Vtama | $19 | 1 payment
|
| Helsinn Therapeutics (U.S.) | Valchlor | $14 | 1 payment
|
2021: $3,651
| AbbVie | Skyrizi | $554 | 50 payments
|
| VYNE Pharmaceuticals | Zilxi | $392 | 11 payments
|
| Sun Pharmaceutical Industries | Ilumya | $278 | 17 payments
|
| Regeneron Healthcare Solutions | Dupixent | $268 | 9 payments
|
| Janssen Scientific Affairs | Tremfya | $249 | 2 payments
|
| Janssen Biotech | Tremfya | $245 | 10 payments
|
| Mayne Pharma | None | $213 | 31 payments
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $205 | 13 payments
|
| Pfizer | Eucrisa | $182 | 12 payments
|
| Amgen | Enbrel | $158 | 7 payments
|
| Lilly USA | Taltz | $156 | 9 payments
|
| Ucb | Cimzia | $145 | 9 payments
|
| Almirall | Seysara | $138 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $100 | 6 payments
|
| LEO Pharma | Enstilar | $87 | 5 payments
|
| Galderma Laboratories L.P. | Aklief | $80 | 5 payments
|
| Medimetriks Pharmaceuticals | Clindacin Etz | $74 | 2 payments
|
| EPI Health | Cloderm | $50 | 3 payments
|
| Genzyme | None | $39 | 2 payments
|
| Incyte | Opzelura | $21 | 1 payment
|
| Nabriva Therapeutics plc | Sivextro | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1821432899
- Licence
- GA RN218402
- Trained
- Emory University School of Medicine, 2012
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 220 Graces Way, Columbia, SC, 29229
- NPI first listed
- 2013-04-22
- NPI last updated
- 2024-07-16
- NPI record certified
- 2024-07-16
This is when the NPI record was last certified, not a medical board exam.